English and Spanish support
Patient information and care coordination are available in English and Spanish. Share approved copy in the language your audience uses.
Looking for treatment for yourself? → See plans and prices
Join the REMEVi creator affiliate program. Introduce your audience to medically supervised GLP-1 weight care, with information and care coordination in English and Spanish.
Apply to partnerFor creators, reviewers, newsletters and podcasts.
An organization or licensed clinician?A direct program with a personal link and clearly defined milestones.
Your partner agreement defines eligibility, attribution and payment terms.
Your audience trusts your judgment. Explore the care, the people and the details before you put your name beside ours.
Patient information and care coordination are available in English and Spanish. Share approved copy in the language your audience uses.
Medication, medical care and shipping are included in GLP-1 plans. Current pricing shows the full charge and billing interval before someone chooses.
A licensed clinician determines whether treatment is appropriate. Explore our medical team and named pharmacies, and check the LegitScript registry.
A direct relationship, from your application to your monthly statement.
Tell us about your audience, where they live and what they want to understand about GLP-1 care.
A 15-minute call, then a short creative brief and a plain-language agreement. No script — you know your audience; we give you context and the rules.
You get a personal link that takes people straight to the bilingual intake. Anyone who starts care through it is yours for 90 days.
Receive a monthly statement of eligible commission milestones. Payments are by ACH or PayPal, under your partner agreement.
Creators with an audience interested in medically supervised weight care can apply below. Honest, useful content matters more than a sales pitch.
Coupon, cashback and toolbar sites, incentivized traffic and paid search on our brand are not a fit.
Apply to partnerWe provide a creative brief and approved disclosure language. Keep your voice; keep the facts accurate.
Make paid-partnership disclosures easy to see, beside the endorsement and in the same language. Review the platform’s rules before publishing.
FTC disclosure guidanceFDA on compounded medicationsTell us about your audience. We review your application and contact you by email if there is a fit.
If we move forward, we discuss your audience and content, share the agreement and creative brief, and prepare your personal link.
Required fields are marked with an asterisk. This application is for creator partners.
Questions? Email our partner teamWhen a patient you referred makes their first payment and it clears — not when they click, and not when they fill out the questionnaire. The second $75 pays when that patient is still active through the retention milestone in your agreement. Statements and payments are monthly, under your partner agreement.
Your personal link carries your partner code into the intake, and we attribute that person to you for 90 days from the click. If they come back later and start through the site directly inside those 90 days, they're still yours. Someone who is already a REMEVi patient can't be referred.
A first payment that's refunded or disputed within 30 days doesn't count. Everything else stands.
Yes. We provide approved Spanish copy for disclosures and program basics. Patient information and care coordination are available in English and Spanish.
You can name the brand-name medications to explain what GLP-1s are. You can't say REMEVi's medication is the same as, a generic of, or "just like" any of them. It's a compounded medication from a licensed pharmacy, and every post says so.
Yes, on different terms — we don't pay licensed clinicians or organizations per patient, ever. Email partners@remevihealth.com and we'll set up education, a flat sponsorship, or a community session instead.
Yes — a direct one. REMEVi pays creators, review sites, newsletters and podcasts a flat amount for each patient who starts medically supervised GLP-1 weight-loss care through their personal link. There is no network to join and no fee taken from your payout.
$75 when a new patient you referred makes their first payment and it clears, and $75 more when they're still an active patient through the retention milestone in your agreement — $150 per patient, no minimum payout, paid monthly.
No. It's run directly: you apply on this page, we send you a personal link and a short brief, and statements come from us. If you already promote telehealth or health programs through a network, you can run REMEVi alongside them — the program is non-exclusive.
A fit: creators, reviewers, newsletter writers and podcast hosts whose audience asks about GLP-1 weight loss, in English or Spanish. Not a fit: coupon, cashback and toolbar sites, incentivised or paid-search traffic on our brand name, and anyone who wants to promise results. Licensed clinicians and community organizations are welcome on different terms (see above).